ListarInstituto de Biomedicina de Sevilla (IBIS) por materia "Immunotherapy"
Mostrando ítems 1-1 de 1
-
Artículo
Primary and acquired resistance to immunotherapy in lung cancer: unveiling the mechanisms underlying of immune checkpoint blockade therapy
(MDPI, 2020-12-11)After several decades without maintained responses or long-term survival of patients with lung cancer, novel therapies ...